Ascentage Pharma Group Inc.

This early-stage study is testing whether adding an experimental drug called APG-1252 to an existing lung cancer medication (osimertinib) is safe and might help control tumors that have started growing again. The trial will enroll about 80 adults with advanced non-small cell lung…